← All Phreesia, INC filings

Phreesia, INC 10-K annual reports

Annual reports — audited financials, the full risk-factor list, and management’s account of the year.

NYSE
PHR
Phreesia, INC
10-K: Phreesia Swings to Profit in Fiscal 2026, Boosted by Growth
Phreesia reported a significant turnaround to net income of $2.3 million in fiscal year 2026, up from a $58.5 million net loss in the prior year, fueled by strong revenue growth across all segments and the strategic AccessOne acquisition.
NYSE
PHR
Phreesia, INC
10-K: Phreesia Reports Fiscal Year 2025 Results: Revenue Up 18%, Adjusted EBITDA Turns Positive
Phreesia, a healthcare software solutions provider, announced an 18% increase in total revenue for fiscal year 2025, reaching $419.8 million, and a shift to positive adjusted EBITDA of $36.8 million.
NYSE
PHR
Phreesia, INC
10-K: Phreesia Inc. Reports Fiscal Year 2024 Results, Highlights Growth and Strategic Investments
Phreesia Inc.'s 10-K filing reveals a 27% revenue increase to $356.3 million for fiscal year 2024, alongside strategic acquisitions and a focus on margin enhancement.